Welcome to the CAFACHEM 2026 Conference Site
Proudly sponsored by
Current Time: 2026-07-18 08:49
Current Session: Poster Lunch: Applications
(Refresh for the most up to date session!)Abstracts presented in this session:
| Session | Abstract title | Category | Author | |
|---|---|---|---|---|
| P-9 | Rapid access towards MAO-B radiotracers from palladium-catalyzed cross-coupling reactions |
Radiopharmaceuticals for Neurology | Brian Valladares | View |
| P-10 | Development of Radiolabeled Amonafide Derivatives as A GSH-Responsive PET ligand |
Radiopharmaceuticals for Oncology | Nayeong Hwang | View |
| P-11 | Novel PSMA ligands for enhanced 177Lu radiolabeling efficiency, molar activity capacity and biological performance |
Radiopharmaceuticals for Oncology | Paulína Pažítková | View |
| P-12 | Scaling Up Ac-225 Production from the Ra-226(p,2n)Ac-225 Reaction: Can we Automate the Separation of Actinium-225 from Radium-226 Using a Commercial Radiochemistry Module? |
Radiopharmaceuticals for Oncology | Alexander Yordanov | View |
| P-13 | Breaking Barriers: Tight Junction-Directed Radiotheranostic Probes for Metastatic Colorectal Cancer |
Radiopharmaceuticals for Oncology | Ha Tran | View |
| P-14 | Molecular Dynamics Simulation-Based Evaluation of the 5O5T–Compound 3c Complex in Radioligand Therapy (ATX-101) for Structural Stability and Binding Robustness |
Radiopharmaceuticals for Oncology | Punna Rao Suryadevara Suryadevara | View |
| P-15 | Therapeutic Synergy of a MUC13-Targeted Radiopharmaceutical and ATR Inhibition in Colorectal Cancer |
Radiopharmaceuticals for Oncology | Ying Chen | View |